# EDGAR Filing Document

**Accession Number:** 0000745968
**File Stem:** 0001145549-23-017650
**Filing Date:** 2023-3
**Character Count:** 112343
**Document Hash:** e3bec4fed353fb4b1ea9b731fa8c2079
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001145549-23-017650.hdr.sgml**: 20230323

**ACCESSION NUMBER**: 0001145549-23-017650

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230131

**FILED AS OF DATE**: 20230323

**DATE AS OF CHANGE**: 20230323

**PERIOD START**: 20231031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Federated Hermes Equity Funds
- **CENTRAL INDEX KEY:** 0000745968
- **IRS NUMBER:** 251470423
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-04017
- **FILM NUMBER:** 23755288

**BUSINESS ADDRESS:**
- **STREET 1:** 4000 ERICSSON DRIVE
- **CITY:** WARRENDALE
- **STATE:** PA
- **ZIP:** 15086-7561
- **BUSINESS PHONE:** 8003417400

**MAIL ADDRESS:**
- **STREET 1:** 4000 ERICSSON DRIVE
- **CITY:** WARRENDALE
- **STATE:** PA
- **ZIP:** 15086-7561

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FEDERATED EQUITY FUNDS
- **DATE OF NAME CHANGE:** 20200616

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FEDERATED HERMES EQUITY FUNDS
- **DATE OF NAME CHANGE:** 20200615

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FEDERATED EQUITY FUNDS
- **DATE OF NAME CHANGE:** 19950810

## Series and Classes Contracts Data

### Federated Hermes Kaufmann Fund (Series ID: S000009729)

| Class ID   | Class Name           | Ticker Symbol   |
|:---|:---|:---|
| C000026729 | Class A Shares       | KAUAX           |
| C000026730 | Class B Shares       | KAUBX           |
| C000026731 | Class C Shares       | KAUCX           |
| C000026732 | Class R Shares       | KAUFX           |
| C000176447 | Institutional Shares | KAUIX           |
| C000188311 | Class T Shares       |  |

## Nport-Ex

Federated Hermes Kaufmann Fund

Portfolio of Investments

January 31, 2023 (unaudited)

---

| | | |
|:---|:---|:---|
| **Shares or** <br>**Principal** <br>**Amount**<br>|  | **Value** |
|  | COMMON STOCKS—86.5% |  |
|  | **Communication Services—0.3%** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 65000<br><sup>1</sup> <br>| Take-Two Interactive Software, Inc. | $7359950 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 175000<br><sup>1</sup> <br>| ZoomInfo Technologies, Inc. | &nbsp;&nbsp; 4940250 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12300200 |
|  | **Consumer Discretionary—8.1%** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 210000<br><sup>1</sup> <br>| Airbnb, Inc. | &nbsp;&nbsp; 23333100 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 250000<br><sup>1</sup> <br>| Alibaba Group Holding Ltd., ADR | &nbsp;&nbsp; 27550000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 400000<br><sup>1</sup> <br>| Amazon.com, Inc. | &nbsp;&nbsp; 41252000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15850<br><sup>1</sup> <br>| Chipotle Mexican Grill, Inc. | &nbsp;&nbsp; 26095123 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 180000 | Choice Hotels International, Inc. | &nbsp;&nbsp; 22120200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50000<br><sup>1</sup> <br>| Etsy, Inc. | &nbsp;&nbsp; 6879000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 75000<br><sup>1</sup> <br>| Five Below, Inc. | &nbsp;&nbsp; 14784750 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 200000<br><sup>1,2</sup> <br>| Floor & Decor Holdings, Inc. | &nbsp;&nbsp; 18154000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 475000<br><sup>1</sup> <br>| Las Vegas Sands Corp. | &nbsp;&nbsp; 28025000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 57500<br><sup>1</sup> <br>| Lululemon Athletica, Inc. | &nbsp;&nbsp; 17645600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10000<br><sup>1</sup> <br>| Mercadolibre, Inc. | &nbsp;&nbsp; 11816900 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 326000 | Moncler S.p.A | &nbsp;&nbsp; 20423744 |
| &nbsp;&nbsp; 22196000 | NagaCorp Ltd. | &nbsp;&nbsp; 20201161 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 100000 | Nike, Inc., Class B | &nbsp;&nbsp; 12733000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 375000<br><sup>1</sup> <br>| Planet Fitness, Inc. | &nbsp;&nbsp; 31743750 |
| &nbsp;&nbsp;&nbsp; 1092200<br><sup>1,2</sup> <br>| Sportradar Group AG | &nbsp;&nbsp; 13707110 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10000 | Vail Resorts, Inc. | &nbsp;&nbsp; 2623400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 446684 | Wingstop, Inc. | &nbsp;&nbsp; 70786013 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL | &nbsp;&nbsp;&nbsp;&nbsp; 409873851 |
|  | **Consumer Staples—2.8%** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50800 | Costco Wholesale Corp. | &nbsp;&nbsp; 25965912 |
| &nbsp;&nbsp;&nbsp; 1000000 | Philip Morris International, Inc. | &nbsp;&nbsp; 104240000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 547077<br><sup>1</sup> <br>| The Duckhorn Portfolio, Inc. | &nbsp;&nbsp; 8851706 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL | &nbsp;&nbsp;&nbsp;&nbsp; 139057618 |
|  | **Energy—3.3%** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 281700 | Cheniere Energy, Inc. | &nbsp;&nbsp; 43040943 |
| &nbsp;&nbsp;&nbsp; 2000000 | New Fortress Energy, Inc. | &nbsp;&nbsp; 77580000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 178000 | Pioneer Natural Resources, Inc. | &nbsp;&nbsp; 41002300 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 175000 | Williams Cos., Inc. | &nbsp;&nbsp; 5642000 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL | &nbsp;&nbsp;&nbsp;&nbsp; 167265243 |
|  | **Financials—7.8%** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 750000 | Apollo Global Management, Inc. | &nbsp;&nbsp; 53085000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 58900 | BlackRock, Inc. | &nbsp;&nbsp; 44717469 |
| &nbsp;&nbsp;&nbsp; 6800000<br><sup>1</sup> <br>| Blue Owl Capital, Inc. | &nbsp;&nbsp; 85544000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1<br><sup>1,3,4</sup> <br>| FA Private Equity Fund IV LP | &nbsp;&nbsp; 370089 |
| &nbsp;&nbsp;&nbsp; 2102000 | FinecoBank Banca Fineco SPA | &nbsp;&nbsp; 37675879 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 699000 | Hamilton Lane, Inc. | &nbsp;&nbsp; 54424140 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 500000 | KKR & Co., Inc., Class Common | &nbsp;&nbsp; 27905000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 65000 | MSCI, Inc., Class A | &nbsp;&nbsp; 34551400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 140000 | S&P Global, Inc. | &nbsp;&nbsp; 52491600 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL | &nbsp;&nbsp;&nbsp;&nbsp; 390764577 |
|  | **Health Care—38.0%** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 197736<br><sup>1</sup> <br>| 89Bio, Inc. | &nbsp;&nbsp; 2309556 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 110000 | Abbott Laboratories | &nbsp;&nbsp; 12160500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 800000<br><sup>1,2</sup> <br>| Acrivon Therapeutics, Inc. | &nbsp;&nbsp; 12960000 |

---

**1**

------

---

| | | |
|:---|:---|:---|
| **Shares or**<br> **Principal**<br> **Amount**<br>|  | **Value** |
|  | COMMON STOCKS—continued |  |
|  | **Health Care—continued** |  |
| &nbsp;&nbsp;&nbsp; 1929911<br><sup>1</sup> <br>| Albireo Pharma, Inc. | $86189825 |
| &nbsp;&nbsp;&nbsp; 1171662<br><sup>1</sup> <br>| Alector, Inc. | &nbsp;&nbsp; 10334059 |
| &nbsp;&nbsp;&nbsp; 1135000<br><sup>1</sup> <br>| Amphastar Pharmaceuticals, Inc. | &nbsp;&nbsp; 34345100 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 774637<br><sup>1</sup> <br>| Amylyx Pharmaceuticals, Inc. | &nbsp;&nbsp; 30358024 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 663834<br><sup>1,2</sup> <br>| AnaptysBio, Inc. | &nbsp;&nbsp; 16522828 |
| &nbsp;&nbsp;&nbsp; 2000000<br><sup>1</sup> <br>| Annexon, Inc. | &nbsp;&nbsp; 14280000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 156700<br><sup>1</sup> <br>| Apellis Pharmaceuticals, Inc. | &nbsp;&nbsp; 8262791 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 600000<br><sup>1</sup> <br>| Apollo Endosurgery, Inc. | &nbsp;&nbsp; 5898000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1<br><sup>3,4</sup> <br>| Apollo Investment Fund V | &nbsp;&nbsp; 85207 |
| &nbsp;&nbsp;&nbsp; 2452872<br><sup>1</sup> <br>| Arcturus Therapeutics Holdings, Inc. | &nbsp;&nbsp; 51829185 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 717253<br><sup>1</sup> <br>| Argenx SE | &nbsp;&nbsp; 272671623 |
| &nbsp;&nbsp;&nbsp; 2265000<br><sup>1</sup> <br>| aTyr Pharma, Inc. | &nbsp;&nbsp; 5209500 |
| &nbsp;&nbsp;&nbsp; 1215600<br><sup>1</sup> <br>| Avidity Biosciences LLC | &nbsp;&nbsp; 28809720 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 250000<br><sup>1,2</sup> <br>| Century Therapeutics, Inc. | &nbsp;&nbsp; 1142500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 267745<br><sup>1</sup> <br>| Century Therapeutics, Inc. | &nbsp;&nbsp; 1223595 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 454099<br><sup>1</sup> <br>| Cerevel Therapeutics Holdings | &nbsp;&nbsp; 15507481 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 450000<br><sup>1</sup> <br>| Chinook Therapeutics, Inc. | &nbsp;&nbsp; 11371500 |
| &nbsp;&nbsp;&nbsp; 1942492<br><sup>1,3</sup> <br>| Contra Akouos, Inc., Rights | &nbsp;&nbsp; 1534569 |
| &nbsp;&nbsp;&nbsp; 3000000<br><sup>1</sup> <br>| Corcept Therapeutics, Inc. | &nbsp;&nbsp; 68580000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 195000<br><sup>1,2</sup> <br>| CRISPR Therapeutics AG | &nbsp;&nbsp; 9948900 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 452500 | Danaher Corp. | &nbsp;&nbsp; 119631950 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 121500<br><sup>1</sup> <br>| Denali Therapeutics, Inc. | &nbsp;&nbsp; 3677805 |
| &nbsp;&nbsp;&nbsp; 1084800<br><sup>1</sup> <br>| Dexcom, Inc. | &nbsp;&nbsp; 116171232 |
| &nbsp;&nbsp;&nbsp; 6572140<br><sup>1,2</sup> <br>| Dynavax Technologies Corp. | &nbsp;&nbsp; 74790953 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 100000<br><sup>1</sup> <br>| EDAP TMS SA, ADR | &nbsp;&nbsp; 1100000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 290000 | Eli Lilly & Co. | &nbsp;&nbsp; 99803500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 500000<br><sup>1</sup> <br>| Fusion Pharmaceuticals, Inc. | &nbsp;&nbsp; 1515000 |
| &nbsp;&nbsp;&nbsp; 1500000<br><sup>1,2</sup> <br>| Gamida Cell Ltd. | &nbsp;&nbsp; 2400000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 64400<br><sup>1</sup> <br>| Genmab A/S | &nbsp;&nbsp; 25191382 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 679512<br><sup>1,2</sup> <br>| Gracell Biotechnologies, Inc., ADR | &nbsp;&nbsp; 1460951 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 313900<br><sup>1</sup> <br>| Guardant Health, Inc. | &nbsp;&nbsp; 9865877 |
| &nbsp;&nbsp;&nbsp; 1220800<br><sup>1</sup> <br>| IDEAYA Biosciences, Inc. | &nbsp;&nbsp; 20790224 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 39300<br><sup>1</sup> <br>| IDEXX Laboratories, Inc. | &nbsp;&nbsp; 18883650 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 71200<br><sup>1</sup> <br>| Illumina, Inc. | &nbsp;&nbsp; 15251040 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 80400<br><sup>1</sup> <br>| Inspire Medical Systems, Inc. | &nbsp;&nbsp; 20346024 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 130000<br><sup>1</sup> <br>| Insulet Corp. | &nbsp;&nbsp; 37351600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 990741<br><sup>1</sup> <br>| Intellia Therapeutics, Inc. | &nbsp;&nbsp; 42047048 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 59000<br><sup>1</sup> <br>| Intuitive Surgical, Inc. | &nbsp;&nbsp; 14495710 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 164133<br><sup>1,3</sup> <br>| Laronde, Inc. | &nbsp;&nbsp; 3559240 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1<br><sup>1,3,4</sup> <br>| Latin Healthcare Fund | &nbsp;&nbsp; 263909 |
| &nbsp;&nbsp;&nbsp; 1142500<br><sup>1</sup> <br>| Legend Biotech Corp., ADR | &nbsp;&nbsp; 57696250 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 291448<br><sup>1,2</sup> <br>| Lyell Immunopharma, Inc. | &nbsp;&nbsp; 953035 |
| &nbsp;&nbsp;&nbsp; 1462167<br><sup>1,2</sup> <br>| Merus N.V. | &nbsp;&nbsp; 22809805 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 650000<br><sup>1</sup> <br>| Minerva Neurosciences, Inc. | &nbsp;&nbsp; 1553500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 363318<br><sup>1</sup> <br>| Moonlake Immunotherapeutics | &nbsp;&nbsp; 4341650 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 200000<br><sup>1</sup> <br>| Morphic Holding, Inc. | &nbsp;&nbsp; 6546000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 205000<br><sup>1</sup> <br>| Natera, Inc. | &nbsp;&nbsp; 8800650 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 110000 | Novo Nordisk A/S | &nbsp;&nbsp; 15233198 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 530000<br><sup>1</sup> <br>| Orchard Therapeutics PLC | &nbsp;&nbsp; 294998 |
| &nbsp;&nbsp;&nbsp; 7000000<br><sup>1</sup> <br>| Orchard Therapeutics PLC, ADR | &nbsp;&nbsp; 3896200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 220000<br><sup>1</sup> <br>| Privia Health Group, Inc. | &nbsp;&nbsp; 5948800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 100000<br><sup>1</sup> <br>| Prometheus Biosciences, Inc. | &nbsp;&nbsp; 11366000 |
| &nbsp;&nbsp;&nbsp; 1240000 | Regulus Therapeutics, Inc. | &nbsp;&nbsp; 1785600 |
| &nbsp;&nbsp;&nbsp; 1356000<br><sup>1</sup> <br>| Regulus Therapeutics, Inc. | &nbsp;&nbsp; 1952640 |

---

**2**

------

---

| | | |
|:---|:---|:---|
| **Shares or**<br> **Principal**<br> **Amount**<br>|  | **Value** |
|  | COMMON STOCKS—continued |  |
|  | **Health Care—continued** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 180000<br><sup>1</sup> <br>| Repligen Corp. | $33354000 |
| &nbsp;&nbsp;&nbsp; 3215300<br><sup>1,2</sup> <br>| Rezolute, Inc. | &nbsp;&nbsp; 8263321 |
| &nbsp;&nbsp;&nbsp; 3264238<br><sup>1,2</sup> <br>| Rhythm Pharmaceuticals, Inc. | &nbsp;&nbsp; 89276909 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 358200<br><sup>1,2</sup> <br>| Sarepta Therapeutics, Inc. | &nbsp;&nbsp; 44764254 |
| &nbsp;&nbsp;&nbsp; 1540000<br><sup>1,2</sup> <br>| Scynexis, Inc. | &nbsp;&nbsp; 2825900 |
| &nbsp;&nbsp; 11163099<br><sup>1</sup> <br>| Seres Therapeutics, Inc. | &nbsp;&nbsp; 61062152 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 959018<br><sup>1,3</sup> <br>| Soteira, Inc. | &nbsp;&nbsp; 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 59700 | Stryker Corp. | &nbsp;&nbsp; 15152457 |
| &nbsp;&nbsp;&nbsp; 1210000<br><sup>1</sup> <br>| Ultragenyx Pharmaceutical, Inc. | &nbsp;&nbsp; 54849300 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20400 | UnitedHealth Group, Inc. | &nbsp;&nbsp; 10183476 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 500000<br><sup>1</sup> <br>| Veeva Systems, Inc. | &nbsp;&nbsp; 85275000 |
| &nbsp;&nbsp;&nbsp; 1111000<br><sup>1,2</sup> <br>| Verve Therapeutics, Inc. | &nbsp;&nbsp; 25275250 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 627230<br><sup>1,2</sup> <br>| Zentalis Pharmaceuticals, LLC | &nbsp;&nbsp; 14802628 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL | &nbsp;&nbsp; 1918394531 |
|  | **Industrials—7.2%** |  |
| &nbsp;&nbsp;&nbsp; 1315000<br><sup>1</sup> <br>| CoStar Group, Inc. | &nbsp;&nbsp; 102438500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 52600 | Deere & Co. | &nbsp;&nbsp; 22241384 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 352000 | HEICO Corp. | &nbsp;&nbsp; 60174400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 510000<br><sup>1</sup> <br>| Mercury Systems, Inc. | &nbsp;&nbsp; 25492350 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 312000 | Quanta Services, Inc. | &nbsp;&nbsp; 47483280 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 37200 | Rockwell Automation, Inc. | &nbsp;&nbsp; 10491516 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 155000 | Trane Technologies PLC | &nbsp;&nbsp; 27763600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 107000 | Union Pacific Corp. | &nbsp;&nbsp; 21848330 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 159256<br><sup>1</sup> <br>| Upwork, Inc. | &nbsp;&nbsp; 2063958 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 385000 | Wabtec Corp. | &nbsp;&nbsp; 39966850 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50000 | Xylem, Inc. | &nbsp;&nbsp; 5200500 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL | &nbsp;&nbsp;&nbsp;&nbsp; 365164668 |
|  | **Information Technology—5.7%** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 32800<br><sup>1</sup> <br>| Adobe, Inc. | &nbsp;&nbsp; 12147152 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15000<br><sup>1</sup> <br>| Advanced Micro Devices, Inc. | &nbsp;&nbsp; 1127250 |
| &nbsp;&nbsp;&nbsp; 1250000<br><sup>1</sup> <br>| Coupa Software, Inc. | &nbsp;&nbsp; 99900000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10000<br><sup>1</sup> <br>| Crowdstrike Holdings, Inc. | &nbsp;&nbsp; 1059000 |
| &nbsp;&nbsp;&nbsp; 1059322<br><sup>1,3,4</sup> <br>| Expand Networks Ltd. | &nbsp;&nbsp; 0 |
| &nbsp;&nbsp;&nbsp; 1695000<br><sup>1,2</sup> <br>| GDS Holdings Ltd., ADR | &nbsp;&nbsp; 39578250 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6300<br><sup>1</sup> <br>| Keysight Technologies, Inc. | &nbsp;&nbsp; 1129905 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25000 | Marvell Technology, Inc. | &nbsp;&nbsp; 1078750 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 225000<br><sup>1</sup> <br>| Okta, Inc. | &nbsp;&nbsp; 16562250 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10000<br><sup>1</sup> <br>| Palo Alto Networks, Inc. | &nbsp;&nbsp; 1586400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 250000<br><sup>1</sup> <br>| Q2 Holdings, Inc. | &nbsp;&nbsp; 8180000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3751<br><sup>1,3,4</sup> <br>| Sensable Technologies, Inc. | &nbsp;&nbsp; 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 75000<br><sup>1</sup> <br>| ServiceNow, Inc. | &nbsp;&nbsp; 34134750 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 615000<br><sup>1</sup> <br>| Shopify, Inc. | &nbsp;&nbsp; 30301050 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 70000<br><sup>1</sup> <br>| Splunk, Inc. | &nbsp;&nbsp; 6703900 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 83000<br><sup>1</sup> <br>| Tyler Technologies, Inc. | &nbsp;&nbsp; 26789910 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50000<br><sup>1</sup> <br>| Workday, Inc. | &nbsp;&nbsp; 9071500 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL | &nbsp;&nbsp;&nbsp;&nbsp; 289350067 |
|  | **Materials—5.1%** |  |
| &nbsp;&nbsp;&nbsp; 1350000<br><sup>2,4</sup> <br>| Agnico Eagle Mines Ltd. | &nbsp;&nbsp; 76248000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 70000 | Albemarle Corp. | &nbsp;&nbsp; 19701500 |
| &nbsp;&nbsp;&nbsp; 2100543 | Barrick Gold Corp. | &nbsp;&nbsp; 41065615 |
| &nbsp;&nbsp;&nbsp; 1400000 | Newmont Corp. | &nbsp;&nbsp; 74102000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 193600 | Sherwin-Williams Co. | &nbsp;&nbsp; 45803824 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL | &nbsp;&nbsp;&nbsp;&nbsp; 256920939 |

---

**3**

------

---

| | | |
|:---|:---|:---|
| **Shares or**<br> **Principal**<br> **Amount**<br>|  | **Value** |
|  | COMMON STOCKS—continued |  |
|  | **Real Estate—5.7%** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 900000 | Americold Realty Trust, Inc. | $28269000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 325000 | Crown Castle International Corp. | &nbsp;&nbsp; 48135750 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 850000 | Easterly Government Properties, Inc. | &nbsp;&nbsp; 13804000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 300000 | National Storage Affiliates Trust | &nbsp;&nbsp; 12240000 |
| &nbsp;&nbsp;&nbsp;&nbsp; 1825000 | Physicians Realty Trust | &nbsp;&nbsp; 28944500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 400000 | ProLogis, Inc. | &nbsp;&nbsp; 51712000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 250000 | Ryman Hospitality Properties | &nbsp;&nbsp; 23222500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 600000 | STAG Industrial, Inc. | &nbsp;&nbsp; 21360000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50000 | Sun Communities, Inc. | &nbsp;&nbsp; 7843000 |
| &nbsp;&nbsp;&nbsp;&nbsp; 1500000 | VICI Properties, Inc. | &nbsp;&nbsp; 51270000 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL | &nbsp;&nbsp;&nbsp;&nbsp; 286800750 |
|  | **Utilities—2.5%** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 250000 | American Electric Power Co., Inc. | &nbsp;&nbsp; 23490000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 385000 | Duke Energy Corp. | &nbsp;&nbsp; 39443250 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 875000 | NextEra Energy, Inc. | &nbsp;&nbsp; 65301250 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL | &nbsp;&nbsp;&nbsp;&nbsp; 128234500 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL COMMON STOCKS <br>(IDENTIFIED COST $2,880,496,805)<br>| &nbsp;&nbsp; 4364126944 |
|  | U.S. TREASURIES—2.7% |  |
|  | **U.S. Treasury Notes—2.7%** |  |
| $122500000 | United States Treasury Note, 4.125%, 11/15/2032 | &nbsp;&nbsp; 128796978 |
| &nbsp;&nbsp; 10000000 | United States Treasury Note, 4.375%, 10/31/2024 | &nbsp;&nbsp; 10002324 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL U.S. TREASURIES <br>(IDENTIFIED COST $135,746,243)<br>| &nbsp;&nbsp;&nbsp;&nbsp; 138799302 |
|  | CORPORATE BONDS—0.4% |  |
|  | **Consumer Discretionary—0.2%** |  |
| &nbsp;&nbsp; 3000000 | Airbnb, Inc., Conv. Bond, 0.000%, 3/15/2026 | &nbsp;&nbsp; 2616816 |
| &nbsp;&nbsp; 3000000 | Mercadolibre, Inc., Sr. Unsecd. Note, 2.375%, 1/14/2026 | &nbsp;&nbsp; 2718765 |
| &nbsp;&nbsp; 3200000 | NagaCorp Ltd., Sr. Unsecd. Note, 7.950%, 7/6/2024 | &nbsp;&nbsp; 2976000 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8311581 |
|  | **Financials—0.1%** |  |
| &nbsp;&nbsp; 3000000 | Starwood Property Trust, Inc., Conv. Bond, 4.375%, 4/1/2023 | &nbsp;&nbsp; 2995761 |
|  | **Health Care—0.1%** |  |
| &nbsp;&nbsp; 3000000 | Illumina, Inc., Conv. Bond, 0.000%, 8/15/2023 | &nbsp;&nbsp; 2921514 |
| &nbsp;&nbsp; 2000000 | NuVasive, Inc., Conv. Bond, 1.000%, 6/1/2023 | &nbsp;&nbsp; 1964698 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4886212 |
|  | **Information Technology—0.0%** |  |
| &nbsp;&nbsp; 3000000 | DocuSign, Inc., Conv. Bond, 0.000%, 1/15/2024 | &nbsp;&nbsp; 2869026 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL CORPORATE BONDS <br>(IDENTIFIED COST $18,863,750)<br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19062580 |
|  | PREFERRED STOCKS—0.2% |  |
|  | **Financials—0.0%** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25000 | JPMorgan Chase & Co., 5.750% | &nbsp;&nbsp; 624500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25000<br><sup>2</sup> <br>| Wells Fargo & Co., 5.625% | &nbsp;&nbsp; 617500 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1242000 |
|  | **Health Care—0.2%** |  |
| &nbsp;&nbsp;&nbsp;&nbsp; 1903967<br><sup>3</sup> <br>| CeQur SA | &nbsp;&nbsp; 10622576 |
|  | **Information Technology—0.0%** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 679348<br><sup>1,3,4</sup> <br>| Multiplex, Inc., Pfd., Series C | &nbsp;&nbsp; 0 |
|  | **Real Estate—0.0%** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10000<br><sup>2</sup> <br>| Public Storage, 4.000% | &nbsp;&nbsp; 188500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10000 | Public Storage, 4.625% | &nbsp;&nbsp; 214100 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 402600 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL PREFERRED STOCKS <br>(IDENTIFIED COST $16,982,326)<br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12267176 |

---

**4**

------

---

| | | |
|:---|:---|:---|
| **Shares or**<br> **Principal**<br> **Amount**<br>|  | **Value** |
|  | WARRANTS—0.2% |  |
|  | **Health Care—0.2%** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 801900<br><sup>1</sup> <br>| Catabasis Pharmaceuticals, Inc., Warrants 6/22/2023 | $481 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 421550<br><sup>1</sup> <br>| Catabasis Pharmaceuticals, Inc., Warrants 2/8/2024 | &nbsp;&nbsp; 84900 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 200970<br><sup>1</sup> <br>| Rezolute, Inc., Warrants 10/8/2027 | &nbsp;&nbsp; 158465 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 56800<br><sup>1</sup> <br>| Rezolute, Inc., Warrants 1/1/2099 | &nbsp;&nbsp; 145976 |
| &nbsp;&nbsp;&nbsp; 1690301<br><sup>1</sup> <br>| Rezolute, Inc., Warrants 12/31/2099 | &nbsp;&nbsp; 4344074 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 101700<br><sup>1</sup> <br>| Scynexis, Inc., Warrants 3/8/2023 | &nbsp;&nbsp; 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 853000<br><sup>1</sup> <br>| Scynexis, Inc., Warrants 5/21/2024 | &nbsp;&nbsp; 56980 |
| &nbsp;&nbsp;&nbsp; 1706000<br><sup>1</sup> <br>| Scynexis, Inc., Warrants 1/1/2099 | &nbsp;&nbsp; 3130510 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 167251<br><sup>1</sup> <br>| Scynexis, Inc., Warrants 4/26/2029 | &nbsp;&nbsp; 181802 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL WARRANTS <br>(IDENTIFIED COST $17,450,879)<br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8103188 |
|  | INVESTMENT COMPANIES—13.9% |  |
| &nbsp;&nbsp; 45476772 | Federated Hermes Government Obligations Fund, Premier Shares, 4.19%<sup>5</sup> <br>| &nbsp;&nbsp; 45476772 |
| 656177608 | Federated Hermes Institutional Prime Value Obligations Fund, Institutional Shares, 4.41%<sup>5</sup> <br>| &nbsp;&nbsp; 656177608 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL INVESTMENT COMPANIES <br>(IDENTIFIED COST $701,256,025)<br>| &nbsp;&nbsp;&nbsp;&nbsp; 701654380 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL INVESTMENT IN SECURITIES—103.9% <br>(IDENTIFIED COST $3,770,796,028)<br>| &nbsp;&nbsp; 5244013570 |
|  | &nbsp;&nbsp;&nbsp;&nbsp; OTHER ASSETS AND LIABILITIES - NET—(3.9)%<sup>6</sup> <br>| &nbsp;&nbsp;&nbsp; (195931273) |
|  | &nbsp;&nbsp;&nbsp;&nbsp; TOTAL NET ASSETS—100% | $5048082297 |

---

**5**

------

An affiliated company is a company in which the Fund, alone or in combination with other funds, has ownership of at least 5% of the voting shares. Transactions with the affiliated companies during the period ended January 31, 2023, were as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Affiliated** | **Value as of** <br>**10/31/2022**<br>| **Purchases** <br>**at Cost\***<br>| **Proceeds** <br>**from Sales\***<br>| **Change in** <br>**Unrealized** <br>**Appreciation/** <br>**Depreciation\***<br>| **Net** <br>**Realized Gain/** <br>**(Loss)\***<br>| **Value as of** <br>**1/31/2023**<br>| **Shares** <br>**Held as of** <br>**1/31/2023**<br>| **Dividend** <br>**Income\***<br>|
| **Health Care:** |  |  |  |  |  |  |  |  |
| Albireo Pharma, Inc. | $22744819 | $36073864 | $— | $27371142 | $— | $86189825 | &nbsp;&nbsp; 1929911 | $— |
| Alector, Inc.\*\* | $20470000 | $— | $(8881254) | $7780513 | $(9035200) | $10334059 | &nbsp;&nbsp; 1171662 | $— |
| Amphastar Pharmaceuticals, Inc. | $35071500 | $— | $— | $(726400) | $— | $34345100 | &nbsp;&nbsp; 1135000 | $— |
| AnaptysBio, Inc.\*\* | $32248588 | $— | $(11199573) | $(3220425) | $(1305762) | $16522828 | &nbsp;&nbsp;&nbsp;&nbsp; 663834 | $— |
| Annexon, Inc. | $9560000 | $— | $— | $4720000 | $— | $14280000 | &nbsp;&nbsp; 2000000 | $— |
| Arcturus Therapeutics Holdings, Inc. | $34892010 | $8219086 | $— | $8718089 | $— | $51829185 | &nbsp;&nbsp; 2452872 | $— |
| aTyr Pharma, Inc. | $5594550 | $— | $— | $(385050) | $— | $5209500 | &nbsp;&nbsp; 2265000 | $— |
| Avidity Biosciences LLC\*\* | $16065000 | $1562850 | $— | $11181870 | $— | $28809720 | &nbsp;&nbsp; 1215600 | $— |
| Dynavax Technologies Corp. | $75251003 | $— | $— | $(460050) | $— | $74790953 | &nbsp;&nbsp; 6572140 | $— |
| Fusion Pharmaceuticals, Inc. | $1237500 | $— | $— | $277500 | $— | $1515000 | &nbsp;&nbsp;&nbsp;&nbsp; 500000 | $— |
| Gamida Cell Ltd.\*\* | $2685000 | $— | $— | $(285000) | $— | $2400000 | &nbsp;&nbsp; 1500000 | $— |
| IDEAYA Biosciences, Inc. | $20619312 | $— | $— | $170912 | $— | $20790224 | &nbsp;&nbsp; 1220800 | $— |
| Merus N.V. | $31057500 | $2591464 | $(3170350) | $(4833292) | $(2835517) | $22809805 | &nbsp;&nbsp; 1462167 | $— |
| Minerva Neurosciences, Inc. | $1722500 | $— | $— | $(169000) | $— | $1553500 | &nbsp;&nbsp;&nbsp;&nbsp; 650000 | $— |
| Orchard Therapeutics PLC | $239666 | $— | $— | $55332 | $— | $294998 | &nbsp;&nbsp;&nbsp;&nbsp; 530000 | $— |
| Orchard Therapeutics PLC, ADR | $3165400 | $— | $— | $730800 | $— | $3896200 | &nbsp;&nbsp; 7000000 | $— |
| Regulus Therapeutics, Inc. | $1922000 | $— | $— | $(136400) | $— | $1785600 | &nbsp;&nbsp; 1240000 | $— |
| Regulus Therapeutics, Inc. | $2101800 | $— | $— | $(149160) | $— | $1952640 | &nbsp;&nbsp; 1356000 | $— |
| Rezolute, Inc. | $5433857 | $— | $— | $2829464 | $— | $8263321 | &nbsp;&nbsp; 3215300 | $— |
| Rezolute, Inc., Warrants 10/8/2027 | $106554 | $— | $— | $51911 | $— | $158465 | &nbsp;&nbsp;&nbsp;&nbsp; 200970 | $— |
| Rezolute, Inc., Warrants 1/1/2099 | $95992 | $— | $— | $49984 | $— | $145976 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 56800 | $— |
| Rezolute, Inc., Warrants 12/31/2099 | $2856609 | $— | $— | $1487465 | $— | $4344074 | &nbsp;&nbsp; 1690301 | $— |
| Rhythm Pharmaceuticals, Inc. | $96828990 | $— | $(17884582) | $2960376 | $7372125 | $89276909 | &nbsp;&nbsp; 3264238 | $— |
| Scynexis, Inc. | $3557400 | $— | $— | $(731500) | $— | $2825900 | &nbsp;&nbsp; 1540000 | $— |
| Scynexis, Inc., Warrants 3/8/2023 | $— | $— | $— | $— | $— | $— | &nbsp;&nbsp;&nbsp;&nbsp; 101700 | $— |
| Scynexis, Inc., Warrants 5/21/2024 | $136395 | $— | $— | $(79415) | $— | $56980 | &nbsp;&nbsp;&nbsp;&nbsp; 853000 | $— |
| Scynexis, Inc., Warrants 1/1/2099 | $3940860 | $— | $— | $(810350) | $— | $3130510 | &nbsp;&nbsp; 1706000 | $— |
| Scynexis, Inc., Warrants 4/26/2029 | $241193 | $— | $— | $(59391) | $— | $181802 | &nbsp;&nbsp;&nbsp;&nbsp; 167251 | $— |
| Seres Therapeutics, Inc. | $106231400 | $— | $(4506753) | $(39065701) | $(1596794) | $61062152 | 11163099 | $— |
| Soteira, Inc. | $— | $— | $— | $— | $— | $— | &nbsp;&nbsp;&nbsp;&nbsp; 959018 | $— |
| Ultragenyx Pharmaceutical, Inc.\*\* | $60690000 | $— | $(12413052) | $8065355 | $(1493003) | $54849300 | &nbsp;&nbsp; 1210000 | $— |
| Affiliated issuers no longer in the portfolio <br> at period end<br>| $25582620 | $— | $(25815719) | $1271410 | $(7866794) | $— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | $— |
| &nbsp;&nbsp;&nbsp;&nbsp; TOTAL OF AFFILIATED COMPANIES <br>TRANSACTIONS<br>| $622350018 | $48447264 | $(83871283) | $26610989 | $(16760945) | $603604526 | 60992663 | $— |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* *A portion of the amount shown was recorded when the Fund no longer had ownership of at least 5% of the voting shares.*

\*\* *At January 31, 2023, the Fund no longer has ownership of at least 5% of the voting shares.*

**6**

------

Affiliated fund holdings are investment companies which are managed by the Adviser or an affiliate of the Adviser. Transactions with affiliated fund holdings during the period ended January 31, 2023, were as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Federated** <br>**Hermes** <br>**Government** <br>**Obligations** <br>**Fund,** <br>**Premier** <br>**Shares\***<br>| **Federated** <br>**Hermes** <br>**Institutional** <br>**Prime Value** <br>**Obligations** <br>**Fund,** <br>**Institutional** <br>**Shares\***<br>| **Total of** <br>**Affiliated** <br>**Transactions**<br>|
| Value as of 10/31/2022 | $47261098 | $849229625 | $896490723 |
| Purchases at Cost | $149740066 | $497433285 | $647173351 |
| Proceeds from Sales | $(151524392) | $(691005005) | $(842529397) |
| Change in Unrealized Appreciation/Depreciation | $— | $441594 | $441594 |
| Net Realized Gain/(Loss) | $— | $78109 | $78109 |
| Value as of 1/31/2023 | $45476772 | $656177608 | $701654380 |
| Shares Held as of 1/31/2023 | &nbsp;&nbsp;&nbsp;&nbsp; 45476772 | &nbsp;&nbsp; 656177608 | &nbsp;&nbsp; 701654380 |
| Dividend Income | $— | $10100607 | $10100607 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* *All or a portion of the balance/activity for the fund relates to cash collateral received on securities lending transactions.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| 1 | *Non-income-producing security.* |
| 2 | *All or a portion of these securities are temporarily on loan to unaffiliated broker/dealers. As of January 31, 2023, securities subject to this type of arrangement* <br> *and related collateral were as follows:*<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| **Fair Value of** <br>**Securities Loaned**<br>| **Collateral** <br>**Received**<br>|
| $140703336 | $165819470 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| 3 | *Market quotations and price evaluations are not available. Fair value determined using significant unobservable inputs in accordance with procedures established* <br> *by and under the general supervision of the Fund's Adviser acting through its Valuation Committee.*<br>|
| 4 | *Denotes a restricted security that either: (a) cannot be offered for public sale without first being registered, or availing of an exemption from registration, under* <br> *the Securities Act of 1933; or (b) is subject to a contractual restriction on public sales. At January 31, 2023, these restricted securities amounted to $76,967,205,* <br> *which represented 1.5% of total net assets.*<br>|

---

Additional information on restricted securities held at January 31, 2023, is as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Security** | **Acquisition** <br>**Date**<br>| **Cost** | **Value** |
| Agnico Eagle Mines Ltd. | 12/26/2018 | $59580458 | $76248000 |
| Apollo Investment Fund V | &nbsp;&nbsp; 5/18/2001 | $0 | $85207 |
| Expand Networks Ltd. | &nbsp;&nbsp; 9/22/2000 | $2500000 | $0 |
| FA Private Equity Fund IV LP | &nbsp;&nbsp;&nbsp; 3/4/2002 | $0 | $370089 |
| Latin Healthcare Fund | 11/28/2000 | $0 | $263909 |
| Multiplex, Inc., Pfd., Series C | &nbsp;&nbsp; 2/22/2001 | $5000001 | $0 |
| Sensable Technologies, Inc. | 10/15/2004 | $0 | $0 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

5 *7-day net yield.* <br> 6 *Assets, other than investments in securities, less liabilities.*

Note: The categories of investments are shown as a percentage of total net assets at January 31, 2023.

**Investment Valuation** 

In calculating its net asset value (NAV), the Fund generally values investments as follows:

◾ Equity securities listed on an exchange or traded through a regulated market system are valued at their last reported sale price or official closing price in their principal exchange or market.

◾ Shares of other mutual funds or non-exchange-traded investment companies are valued based upon their reported NAVs, or NAV per share practical expedient, as applicable.

◾ Fixed-income securities are fair valued using price evaluations provided by a pricing service approved by Federated Equity Management Company of Pennsylvania (the "Adviser").

◾ Derivative contracts listed on exchanges are valued at their reported settlement or closing price, except that options are valued at the mean of closing bid and ask quotations.

◾ Over-the-counter (OTC) derivative contracts are fair valued using price evaluations provided by a pricing service approved by the Adviser.

◾ For securities that are fair valued in accordance with procedures established by and under the general supervision of the Adviser, certain factors may be considered, such as: the last traded or purchase price of the security, information obtained by contacting the issuer or dealers, analysis of the issuer's financial statements or other available documents, fundamental analytical data, the nature and

**7**

------

duration of restrictions on disposition, the movement of the market in which the security is normally traded, public trading in similar securities or derivative contracts of the issuer or comparable issuers, movement of a relevant index, or other factors including but not limited to industry changes and relevant government actions.

If any price, quotation, price evaluation or other pricing source is not readily available when the NAV is calculated, if the Fund cannot obtain price evaluations from a pricing service or from more than one dealer for an investment within a reasonable period of time as set forth in the Adviser's valuation policies and procedures for the Fund, or if information furnished by a pricing service, in the opinion of the Adviser's valuation committee ("Valuation Committee"), is deemed not representative of the fair value of such security, the Fund uses the fair value of the investment determined in accordance with the procedures described below. There can be no assurance that the Fund could obtain the fair value assigned to an investment if it sold the investment at approximately the time at which the Fund determines its NAV per share, and the actual value obtained could be materially different.

**Fair Valuation and Significant Events Procedures** 

Pursuant to Rule 2a-5 under the Investment Company Act, the Fund's Board of Trustees (the "Trustees") have designated the Adviser as the Fund's valuation designee to perform any fair value determinations for securities and other assets held by the Fund. The Adviser is subject to the Trustees' oversight and certain reporting and other requirements intended to provide the Trustees the information needed to oversee the Adviser's fair value determinations.

The Adviser, acting through its Valuation Committee, is responsible for determining the fair value of investments for which market quotations are not readily available. The Valuation Committee is comprised of officers of the Adviser and certain of the Adviser's affiliated companies and determines fair value and oversees the calculation of the NAV. The Valuation Committee is also authorized to use pricing services to provide fair value evaluations of the current value of certain investments for purposes of calculating the NAV. The Valuation Committee employs various methods for reviewing third-party pricing-service evaluations including periodic reviews of third-party pricing services' policies, procedures and valuation methods (including key inputs, methods, models and assumptions), transactional back-testing, comparisons of evaluations of different pricing services, and review of price challenges by the Adviser based on recent market activity. In the event that market quotations and price evaluations are not available for an investment, the Valuation Committee determines the fair value of the investment in accordance with procedures adopted by the Adviser. The Trustees periodically review the fair valuations made by the Valuation Committee. The Trustees have also approved the Adviser's fair valuation and significant events procedures as part of the Fund's compliance program and will review any changes made to the procedures.

Factors considered by pricing services in evaluating an investment include the yields or prices of investments of comparable quality, coupon, maturity, call rights and other potential prepayments, terms and type, reported transactions, indications as to values from dealers and general market conditions. Some pricing services provide a single price evaluation reflecting the bid-side of the market for an investment (a "bid" evaluation). Other pricing services offer both bid evaluations and price evaluations indicative of a price between the prices bid and ask for the investment (a "mid" evaluation). The Fund normally uses bid evaluations for any U.S. Treasury and Agency securities, mortgage-backed securities and municipal securities. The Fund normally uses mid evaluations for any other types of fixed-income securities and any OTC derivative contracts. In the event that market quotations and price evaluations are not available for an investment, the fair value of the investment is determined in accordance with procedures adopted by the Adviser.

The Adviser has also adopted procedures requiring an investment to be priced at its fair value whenever the Valuation Committee determines that a significant event affecting the value of the investment has occurred between the time as of which the price of the investment would otherwise be determined and the time as of which the NAV is computed. An event is considered significant if there is both an affirmative expectation that the investment's value will change in response to the event and a reasonable basis for quantifying the resulting change in value. Examples of significant events that may occur after the close of the principal market on which a security is traded, or after the time of a price evaluation provided by a pricing service or a dealer, include:

◾ With respect to securities traded principally in foreign markets, significant trends in U.S. equity markets or in the trading of foreign securities index futures contracts;

◾ Political or other developments affecting the economy or markets in which an issuer conducts its operations or its securities are traded;

◾ Announcements concerning matters such as acquisitions, recapitalizations, litigation developments, or a natural disaster affecting the issuer's operations or regulatory changes or market developments affecting the issuer's industry.

The Adviser has adopted procedures whereby the Valuation Committee uses a pricing service to provide factors to update the fair value of equity securities traded principally in foreign markets from the time of the close of their respective foreign stock exchanges to the pricing time of the Fund. For other significant events, the Fund may seek to obtain more current quotations or price evaluations from alternative pricing sources. If a reliable alternative pricing source is not available, the Valuation Committee will determine the fair value of the investment in accordance with the fair valuation procedures approved by the Adviser. The Trustees periodically review fair valuations made in response to significant events.

Various inputs are used in determining the value of the Fund's investments. These inputs are summarized in the three broad levels listed below:

Level 1—quoted prices in active markets for identical securities.

Level 2—other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.). Also includes securities valued at amortized cost.

Level 3—significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not an indication of the risk associated with investing in those securities.

**8**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>The following is a summary of the inputs used, as of January 31, 2023, in valuing the Fund's assets carried at fair value:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Valuation Inputs** | **Valuation Inputs** | **Valuation Inputs** | **Valuation Inputs** | **Valuation Inputs** |
|  | **Level 1—** <br>**Quoted** <br>**Prices**<br>| **Level 2—** <br>**Other** <br>**Significant** <br>**Observable** <br>**Inputs**<br>| **Level 3—** <br>**Significant** <br>**Unobservable** <br>**Inputs**<br>| **Total** |
| **Equity Securities:** |  |  |  |  |
| Common Stocks |  |  |  |  |
| &nbsp;&nbsp; Domestic | $3605534562 | $— | $5813014 | $3611347576 |
| &nbsp;&nbsp; International | &nbsp;&nbsp;&nbsp;&nbsp; 361382381 | &nbsp;&nbsp; 391396987 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 752779368 |
| Preferred Stocks |  |  |  |  |
| &nbsp;&nbsp; International | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; 10622576 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10622576 |
| &nbsp;&nbsp; Domestic | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1644600 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1644600 |
| **Debt Securities:** |  |  |  |  |
| U.S. Treasuries | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; 138799302 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 138799302 |
| Corporate Bonds | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 19062580 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19062580 |
| Warrants | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4490050 | &nbsp;&nbsp;&nbsp;&nbsp; 3613138 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8103188 |
| **Investment Companies** | &nbsp;&nbsp;&nbsp;&nbsp; 701654380 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 701654380 |
| &nbsp;&nbsp;&nbsp;&nbsp; TOTAL SECURITIES | $4674705973 | $552872007 | $16435590 | $5244013570 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

The following acronym(s) are used throughout this portfolio: <br> ADR —American Depositary Receipt

**9**

------

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Federated Hermes Equity Funds

- **b. Investment Company Act file number:** 811-04017

- **c. CIK number of Registrant:** 0000745968

- **d. LEI of Registrant:** 254900QLYYRKC7NVWP04

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** Federated Hermes Funds

  - **City:** Warrendale

  - **State:** PA

  - **Foreign country:** US

  - **Zip / Postal Code:** 15086-7561

  - **Telephone number:** 8003417400

**Item A.2. Information about the Series.**

- **a. Name of Series:** Federated Hermes Kaufmann Fund

- **b. EDGAR series identifier (if any):** S000009729

- **c. LEI of Series:** Y12J4W1OKXBDT55MIP60

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2023-10-31

- **b. Date as of which information is reported:** 2023-01-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $5248749791.64

**Total Liabilities:** $201005215.56

**Net Assets:** $5047744576.08

**Cash Not Reported:** $51186.20

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000026729 | 2.31%                | -4.51%               | 4.94%                |
| Class ID C000026730 | 2.33%                | -4.55%               | 4.76%                |
| Class ID C000026731 | 2.33%                | -4.56%               | 4.78%                |
| Class ID C000026732 | 2.09%                | -4.50%               | 4.93%                |
| Class ID C000176447 | 2.21%                | -4.52%               | 5.14%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $62157121.69             | $51496480.58                               |
| Month 2  | $52933113.83             | $-285895784.24                             |
| Month 3  | $57595719.01             | $177114530.02                              |

### Schedule of Portfolio Investments

| Name                                                        | Title                                                | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| CONTRA AKOUOS INC                                           | CONTRA AKOUOS INC                                    | CUSIP: 009CVR036<br>LEI: N/A                  | N/A              | DE               |  | US        |   1942492 | NS      | $1534568.68   | 0.03%             |  |  |  | No            |                  3 | On Loan: No      |
| Amylyx Pharmaceuticals Inc                                  | Amylyx Pharmaceuticals Inc                           | CUSIP: 03237H101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    774637 | NS      | $30358024.03  | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Albireo Pharma Inc                                          | Albireo Pharma Inc                                   | CUSIP: 01345P106<br>LEI: 549300835H8LC7O8VC29 | Long             | EC               | CORP              | US        |   1897898 | NS      | $84760124.68  | 1.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Cheniere Energy Inc                                         | Cheniere Energy Inc                                  | CUSIP: 16411R208<br>LEI: MIHC87W9WTYSYZWV1J40 | Long             | EC               | CORP              | US        |    265000 | NS      | $40489350.00  | 0.80%             |  |  |  | No            |                  1 | On Loan: No      |
| CoStar Group Inc                                            | CoStar Group Inc                                     | CUSIP: 22160N109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1315000 | NS      | $102438500.00 | 2.03%             |  |  |  | No            |                  1 | On Loan: No      |
| IDEXX Laboratories Inc                                      | IDEXX Laboratories Inc                               | CUSIP: 45168D104<br>LEI: OGMTXK0LUU1HKV2P0J84 | Long             | EC               | CORP              | US        |     39300 | NS      | $18883650.00  | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Costco Wholesale Corp                                       | Costco Wholesale Corp                                | CUSIP: 22160K105<br>LEI: 29DX7H14B9S6O3FD6V18 | Long             | EC               | CORP              | US        |     50800 | NS      | $25965912.00  | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| DOCUSIGN INC                                                | DocuSign Inc                                         | CUSIP: 256163AD8<br>LEI: 549300Q7PVDWRZ39JG09 | Long             | DBT              | CORP              | US        |   3000000 | PA      | $2869026.00   | 0.06%             | 2024-01-15      | None          | 0.00%                 | No            |                  2 | On Loan: No      |
| Annexon Inc                                                 | Annexon Inc                                          | CUSIP: 03589W102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   2000000 | NS      | $14280000.00  | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Crowdstrike Holdings Inc                                    | Crowdstrike Holdings Inc                             | CUSIP: 22788C105<br>LEI: 549300YBY08K9KM4HX32 | Long             | EC               | CORP              | US        |     10000 | NS      | $1059000.00   | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| NUVASIVE INC                                                | NuVasive Inc                                         | CUSIP: 670704AL9<br>LEI: 549300C5ZB4NZ6TWM881 | Long             | DBT              | CORP              | US        |   2000000 | PA      | $1964698.00   | 0.04%             | 2023-06-01      | Fixed         | 1.00%                 | No            |                  2 | On Loan: No      |
| LARONDE, INC                                                | LARONDE, INC                                         | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    164133 | NS      | $3559240.52   | 0.07%             |  |  |  | No            |                  3 | On Loan: No      |
| Five Below Inc                                              | Five Below Inc                                       | CUSIP: 33829M101<br>LEI: 529900AAXP5Z6BGI7418 | Long             | EC               | CORP              | US        |     75000 | NS      | $14784750.00  | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| GDS Holdings Ltd                                            | GDS Holdings Ltd                                     | CUSIP: 36165L108<br>LEI: 391200MGV8DDCHTN2R77 | Long             | EC               | CORP              | KY        |   1695000 | NS      | $39578250.00  | 0.78%             |  |  |  | No            |                  1 | On Loan: —       |
| Fusion Pharmaceuticals Inc                                  | Fusion Pharmaceuticals Inc                           | CUSIP: 36118A100<br>LEI: N/A                  | Long             | EC               | CORP              | CA        |    500000 | NS      | $1515000.00   | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| KKR & Co Inc                                                | KKR & Co Inc                                         | CUSIP: 48251W104<br>LEI: 54930013V5I303TF9571 | Long             | EC               | CORP              | US        |    500000 | NS      | $27905000.00  | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Inspire Medical Systems Inc                                 | Inspire Medical Systems Inc                          | CUSIP: 457730109<br>LEI: 549300XQQCQ7HCJKTW25 | Long             | EC               | CORP              | US        |     80400 | NS      | $20346024.00  | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Marvell Technology Inc                                      | Marvell Technology Inc                               | CUSIP: 573874104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     25000 | NS      | $1078750.00   | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| MercadoLibre Inc                                            | MercadoLibre Inc                                     | CUSIP: 58733R102<br>LEI: 549300DKPDN9M5S8GB14 | Long             | EC               | CORP              | US        |     10000 | NS      | $11816900.00  | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Natera Inc                                                  | Natera Inc                                           | CUSIP: 632307104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    205000 | NS      | $8800650.00   | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Orchard Therapeutics plc                                    | Orchard Therapeutics plc                             | CUSIP: 68570P101<br>LEI: 21380056R45ONMT94Z50 | Long             | EC               | CORP              | GB        |   7000000 | NS      | $3896200.00   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Ryman Hospitality Properties Inc                            | Ryman Hospitality Properties Inc                     | CUSIP: 78377T107<br>LEI: 529900GCCWW9SRMPJR11 | Long             | EC               |  | US        |    250000 | NS      | $23222500.00  | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Sensable Technologies Inc                                   | SENSABLE TECHNOLOGIES INC RESTRICTED SHARES          | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3751 | NS      | $0.00         | 0.00%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Seres Therapeutics Inc                                      | Seres Therapeutics Inc                               | CUSIP: 81750R102<br>LEI: 549300GMXBE5NUWISF13 | Long             | EC               | CORP              | US        |  11199474 | NS      | $61261122.78  | 1.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Sherwin-Williams Co/The                                     | Sherwin-Williams Co/The                              | CUSIP: 824348106<br>LEI: Z15BMIOX8DDH0X2OBP21 | Long             | EC               | CORP              | US        |    193600 | NS      | $45803824.00  | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Shopify Inc                                                 | Shopify Inc                                          | CUSIP: 82509L107<br>LEI: 549300HGQ43STJLLP808 | Long             | EC               | CORP              | CA        |    615000 | NS      | $30301050.00  | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| VICI Properties Inc                                         | VICI Properties Inc                                  | CUSIP: 925652109<br>LEI: 254900RKH6RY9KCJQH63 | Long             | EC               |  | US        |   1500000 | NS      | $51270000.00  | 1.02%             |  |  |  | No            |                  1 | On Loan: No      |
| CEQUR SA                                                    | FED HERMES KAUFMANN SM CAP CEQUR SA                  | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | CH        |   1903967 | NS      | $10622576.08  | 0.21%             |  |  |  | No            |                  3 | On Loan: No      |
| Tyler Technologies Inc                                      | Tyler Technologies Inc                               | CUSIP: 902252105<br>LEI: 25490040SMU4Z8LBCW70 | Long             | EC               | CORP              | US        |     83000 | NS      | $26789910.00  | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Union Pacific Corp                                          | Union Pacific Corp                                   | CUSIP: 907818108<br>LEI: 549300LMMRSZZCZ8CL11 | Long             | EC               | CORP              | US        |    107000 | NS      | $21848330.00  | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Xylem Inc/NY                                                | Xylem Inc/NY                                         | CUSIP: 98419M100<br>LEI: 549300DF5MV96DRYLQ48 | Long             | EC               | CORP              | US        |     50000 | NS      | $5200500.00   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Zentalis Pharmaceuticals Inc                                | Zentalis Pharmaceuticals Inc                         | CUSIP: 98943L107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    627230 | NS      | $14802628.00  | 0.29%             |  |  |  | No            |                  1 | On Loan: —       |
| Agnico Eagle Mines Ltd                                      | Agnico Eagle Mines Ltd                               | CUSIP: 008474108<br>LEI: YGE0EUBRF7IJOB3QRX76 | Long             | EC               | CORP              | CA        |   1350000 | NS      | $76248000.00  | 1.51%             |  |  |  | Yes           |                  1 | On Loan: —       |
| Alibaba Group Holding Ltd                                   | Alibaba Group Holding Ltd                            | CUSIP: 01609W102<br>LEI: 5493001NTNQJDH60PM02 | Long             | EC               | CORP              | KY        |    250000 | NS      | $27550000.00  | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Cerevel Therapeutics Holdings Inc                           | Cerevel Therapeutics Holdings                        | CUSIP: 15678U128<br>LEI: 254900RJNIRS9COSQR41 | Long             | EC               | CORP              | US        |    454099 | NS      | $15507480.85  | 0.31%             |  |  |  | Yes           |                  1 | On Loan: No      |
| Coupa Software Inc                                          | Coupa Software Inc                                   | CUSIP: 22266L106<br>LEI: 549300Q95ICR2GFL2K37 | Long             | EC               | CORP              | US        |   1111940 | NS      | $88866244.80  | 1.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Dexcom Inc                                                  | DexCom Inc                                           | CUSIP: 252131107<br>LEI: 549300YSK3QDSFR5EU59 | Long             | EC               | CORP              | US        |   1084800 | NS      | $116171232.00 | 2.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Dynavax Technologies Corp                                   | Dynavax Technologies Corp                            | CUSIP: 268158201<br>LEI: 549300T5URIXWDILX594 | Long             | EC               | CORP              | US        |   6572140 | NS      | $74790953.20  | 1.48%             |  |  |  | No            |                  1 | On Loan: —       |
| Eli Lilly & Co                                              | ELI LILLY & CO                                       | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |    290000 | NS      | $99803500.00  | 1.98%             |  |  |  | No            |                  1 | On Loan: No      |
| MERCADOLIBRE INC                                            | MercadoLibre Inc                                     | CUSIP: 58733RAE2<br>LEI: 549300DKPDN9M5S8GB14 | Long             | DBT              | CORP              | US        |   3000000 | PA      | $2718765.00   | 0.05%             | 2026-01-14      | Fixed         | 2.38%                 | No            |                  2 | On Loan: No      |
| Okta Inc                                                    | Okta Inc                                             | CUSIP: 679295105<br>LEI: 549300N8J06I8MRHU620 | Long             | EC               | CORP              | US        |    225000 | NS      | $16562250.00  | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Rockwell Automation Inc                                     | Rockwell Automation Inc                              | CUSIP: 773903109<br>LEI: VH3R4HHBHH12O0EXZJ88 | Long             | EC               | CORP              | US        |     37200 | NS      | $10491516.00  | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Sun Communities Inc                                         | Sun Communities Inc                                  | CUSIP: 866674104<br>LEI: 549300H5GEOJYN41ZG57 | Long             | EC               |  | US        |     50000 | NS      | $7843000.00   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| REGULUS THERAPEUTICS, INC.                                  | REGULUS THERAPEUTICS, INC.                           | CUSIP: 000000000<br>LEI: N/A                  | Long             | EP               | CORP              | US        |   1240000 | NS      | $1785600.00   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S                                            | Novo Nordisk A/S                                     | CUSIP: 000000000<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |    110000 | NS      | $15233197.77  | 0.30%             |  |  |  | No            |                  2 | On Loan: No      |
| Americold Realty Trust Inc                                  | Americold Realty Trust                               | CUSIP: 03064D108<br>LEI: 549300R7N1V5YV8MWH02 | Long             | EC               |  | US        |    900000 | NS      | $28269000.00  | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Amphastar Pharmaceuticals Inc                               | Amphastar Pharmaceuticals Inc                        | CUSIP: 03209R103<br>LEI: 54930055TH0ZLSAQMJ38 | Long             | EC               | CORP              | US        |   1135000 | NS      | $34345100.00  | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Apollo Endosurgery Inc                                      | Apollo Endosurgery Inc                               | CUSIP: 03767D108<br>LEI: 549300OD82W5UIMD4H13 | Long             | EC               | CORP              | US        |    600000 | NS      | $5898000.00   | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Choice Hotels International Inc                             | Choice Hotels International Inc                      | CUSIP: 169905106<br>LEI: 5493003CYRY5RFGTIR97 | Long             | EC               | CORP              | US        |    180000 | NS      | $22120200.00  | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Corcept Therapeutics Inc                                    | Corcept Therapeutics Inc                             | CUSIP: 218352102<br>LEI: 529900EO9LUTFMZ7FF90 | Long             | EC               | CORP              | US        |   3000000 | NS      | $68580000.00  | 1.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corp                                                | Danaher Corp                                         | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |    452500 | NS      | $119631950.00 | 2.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Etsy Inc                                                    | Etsy Inc                                             | CUSIP: 29786A106<br>LEI: 54930089Q7XT501AEA40 | Long             | EC               | CORP              | US        |     50000 | NS      | $6879000.00   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health Inc                                         | Guardant Health Inc                                  | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |    313900 | NS      | $9865877.00   | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Insulet Corp                                                | Insulet Corp                                         | CUSIP: 45784P101<br>LEI: 549300TZTYD2PYN92D43 | Long             | EC               | CORP              | US        |    130000 | NS      | $37351600.00  | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Las Vegas Sands Corp                                        | Las Vegas Sands Corp                                 | CUSIP: 517834107<br>LEI: 549300DUOO1KXOHPM605 | Long             | EC               | CORP              | US        |    475000 | NS      | $28025000.00  | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Legend Biotech Corp                                         | Legend Biotech Corp                                  | CUSIP: 52490G102<br>LEI: 254900EIUFZTW136H859 | Long             | EC               | CORP              | KY        |   1142500 | NS      | $57696250.00  | 1.14%             |  |  |  | No            |                  1 | On Loan: No      |
| NextEra Energy Inc                                          | NextEra Energy Inc                                   | CUSIP: 65339F101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    875000 | NS      | $65301250.00  | 1.29%             |  |  |  | No            |                  1 | On Loan: No      |
| MULTIPLEX INC SERIES C CV PRE                               | MULTIPLEX INC SERIES C CV PRE PRIVATE PLACEMENT      | CUSIP: 000000000<br>LEI: N/A                  | Long             | EP               | CORP              | US        |    679348 | NS      | $0.00         | 0.00%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Repligen Corp                                               | Repligen Corp                                        | CUSIP: 759916109<br>LEI: 54930006QJ0T5AUO1E71 | Long             | EC               | CORP              | US        |    180000 | NS      | $33354000.00  | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Rhythm Pharmaceuticals Inc                                  | Rhythm Pharmaceuticals Inc                           | CUSIP: 76243J105<br>LEI: 529900JPNWXQ8DPLA551 | Long             | EC               | CORP              | US        |   3264238 | NS      | $89276909.30  | 1.77%             |  |  |  | No            |                  1 | On Loan: —       |
| SOTEIRA INC                                                 | SOTEIRA INC COM                                      | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    959018 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| United States Treasury                                      | United States Treasury Note/Bond                     | CUSIP: 91282CFQ9<br>LEI: 254900HROIFWPRGM1V77 | Long             | DBT              | UST               | US        |  10000000 | PA      | $10002324.00  | 0.20%             | 2024-10-31      | Fixed         | 4.38%                 | No            |                  2 | On Loan: No      |
| Veeva Systems Inc                                           | Veeva Systems Inc                                    | CUSIP: 922475108<br>LEI: 549300YZEXPDB92M2F02 | Long             | EC               | CORP              | US        |    500000 | NS      | $85275000.00  | 1.69%             |  |  |  | No            |                  1 | On Loan: No      |
| BLUE OWL CAPITAL                                            | BLUE OWL CAPITAL PIPE DEAL                           | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   6800000 | NS      | $85544000.00  | 1.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Workday Inc                                                 | Workday Inc                                          | CUSIP: 98138H101<br>LEI: 549300J0DYC0N31V7G13 | Long             | EC               | CORP              | US        |     50000 | NS      | $9071500.00   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| REZOLUTE INC WARRANT                                        | REZOLUTE INC   WARRANT STRIKE PRICE 0.39             | CUSIP: 000000000<br>LEI: N/A                  | N/A              | DE               |  | US        |    200970 | NS      | $158464.85    | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Trane Technologies PLC                                      | Trane Technologies PLC                               | CUSIP: 000000000<br>LEI: 549300BURLR9SLYY2705 | Long             | EC               | CORP              | IE        |    155000 | NS      | $27763600.00  | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| AIRBNB INC                                                  | Airbnb Inc                                           | CUSIP: 009066AB7<br>LEI: 549300HMUDNO0RY56D37 | Long             | DBT              | CORP              | US        |   3000000 | PA      | $2616816.00   | 0.05%             | 2026-03-15      | None          | 0.00%                 | No            |                  2 | On Loan: No      |
| Federated Hermes Institutional Prime Value Obligations Fund | Federated Institutional Prime Value Obligations Fund | CUSIP: 60934N583<br>LEI: 254900OXLDDVEP8MMK94 | Long             | EC               | RF                | US        | 655959713 | NS      | $655959712.67 | 13.00%            |  |  |  | No            |                  1 | On Loan: No      |
| REZOLUTE INC                                                | REZOLUTE INC                                         | CUSIP: 000000000<br>LEI: 549300T05L48T72P2G08 | N/A              | DE               |  | US        |   1690301 | NS      | $4344073.57   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Gamida Cell Ltd                                             | Gamida Cell Ltd                                      | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IL        |   1500000 | NS      | $2400000.00   | 0.05%             |  |  |  | No            |                  1 | On Loan: —       |
| Abbott Laboratories                                         | Abbott Laboratories                                  | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |    110000 | NS      | $12160500.00  | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Alector Inc                                                 | Alector Inc                                          | CUSIP: 014442107<br>LEI: 549300Z8RQOIY1JMHC25 | Long             | EC               | CORP              | US        |   1171662 | NS      | $10334058.84  | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Crown Castle Inc                                            | Crown Castle International Corp                      | CUSIP: 22822V101<br>LEI: 54930012H97VSM0I2R19 | Long             | EC               |  | US        |    325000 | NS      | $48135750.00  | 0.95%             |  |  |  | No            |                  1 | On Loan: No      |
| EDAP TMS SA                                                 | EDAP TMS SA                                          | CUSIP: 268311107<br>LEI: N/A                  | Long             | EC               | CORP              | FR        |    100000 | NS      | $1100000.00   | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Adobe Inc                                                   | Adobe Systems Inc                                    | CUSIP: 00724F101<br>LEI: FU4LY2G4933NH2E1CP29 | Long             | EC               | CORP              | US        |     32800 | NS      | $12147152.00  | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Amazon.com Inc                                              | Amazon.com Inc                                       | CUSIP: 023135106<br>LEI: ZXTILKJKG63JELOEG630 | Long             | EC               | CORP              | US        |    400000 | NS      | $41252000.00  | 0.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Apollo Global Management Inc                                | Apollo Global Management Inc                         | CUSIP: 03769M106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    750000 | NS      | $53085000.00  | 1.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Deere & Co                                                  | Deere & Co                                           | CUSIP: 244199105<br>LEI: PWFTNG3EI0Y73OXWDH08 | Long             | EC               | CORP              | US        |     52600 | NS      | $22241384.00  | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Easterly Government Properties Inc                          | Easterly Government Properties Inc                   | CUSIP: 27616P103<br>LEI: 549300ERMCEFC6S8HL77 | Long             | EC               |  | US        |    850000 | NS      | $13804000.00  | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Floor & Decor Holdings Inc                                  | Floor & Decor Holdings Inc                           | CUSIP: 339750101<br>LEI: 549300M5FR3N688XGQ36 | Long             | EC               | CORP              | US        |    200000 | NS      | $18154000.00  | 0.36%             |  |  |  | No            |                  1 | On Loan: —       |
| Ideaya Biosciences Inc                                      | Ideaya Biosciences Inc                               | CUSIP: 45166A102<br>LEI: 549300ULW08F62IJML11 | Long             | EC               | CORP              | US        |   1220800 | NS      | $20790224.00  | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Lyell Immunopharma Inc                                      | Lyell Immunopharma Inc                               | CUSIP: 55083R104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    447332 | NS      | $1462775.64   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| Pioneer Natural Resources Co                                | Pioneer Natural Resources Co                         | CUSIP: 723787107<br>LEI: FY8JBF7CCL2VE4F1B628 | Long             | EC               | CORP              | US        |    178000 | NS      | $41002300.00  | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| JPMorgan Chase & Co                                         | JPMorgan Chase & Co                                  | CUSIP: 48128B655<br>LEI: 8I5DZWZKVSZI1NUHU748 | Long             | EP               | CORP              | US        |     25000 | NS      | $624500.00    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Keysight Technologies Inc                                   | Keysight Technologies Inc                            | CUSIP: 49338L103<br>LEI: 549300GLKVIO8YRCYN02 | Long             | EC               | CORP              | US        |      6300 | NS      | $1129905.00   | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Privia Health Group Inc                                     | Privia Health Group Inc                              | CUSIP: 74276R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    220000 | NS      | $5948800.00   | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Verve Therapeutics Inc                                      | Verve Therapeutics Inc                               | CUSIP: 92539P101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1111000 | NS      | $25275250.00  | 0.50%             |  |  |  | No            |                  1 | On Loan: —       |
| LATIN HEALTHCARE FD                                         | LATIN HEALTHCARE FD PRIVATE PLACE SEALED ENVELOPE    | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |         1 | NS      | $263909.00    | 0.01%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Mercury Systems Inc                                         | Mercury Systems Inc                                  | CUSIP: 589378108<br>LEI: 549300P3B84SGK7HH679 | Long             | EC               | CORP              | US        |    510000 | NS      | $25492350.00  | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| REGULUS THERAPEUTICS,INC                                    | REGULUS THERAPEUTICS,INC                             | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1356000 | NS      | $1952640.00   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Scynexis, Inc.                                              | Scynexis, Inc. Exp 8Mar19                            | CUSIP: 000000000<br>LEI: 529900XBHFGMNTU70154 | N/A              | DE               |  | US        |    101700 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Morphic Holding Inc                                         | Morphic Holding Inc                                  | CUSIP: 61775R105<br>LEI: 549300RWWOUFLHTY1224 | Long             | EC               | CORP              | US        |    200000 | NS      | $6546000.00   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| National Storage Affiliates Trust                           | National Storage Affiliates Trust                    | CUSIP: 637870106<br>LEI: N/A                  | Long             | EC               |  | US        |    300000 | NS      | $12240000.00  | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Newmont Corp                                                | Newmont Corp                                         | CUSIP: 651639106<br>LEI: 549300VSP3RIX7FGDZ51 | Long             | EC               | CORP              | US        |   1400000 | NS      | $74102000.00  | 1.47%             |  |  |  | No            |                  1 | On Loan: No      |
| NIKE Inc                                                    | NIKE Inc                                             | CUSIP: 654106103<br>LEI: 787RXPR0UX0O0XUXPZ81 | Long             | EC               | CORP              | US        |    100000 | NS      | $12733000.00  | 0.25%             |  |  |  | No            |                  1 | On Loan: No      |
| PUBLIC STORAGE                                              | Public Storage                                       | CUSIP: 74460W420<br>LEI: 549300LMZF40TKJ6DM64 | Long             | EP               |  | US        |     10000 | NS      | $188500.00    | 0.00%             |  |  |  | No            |                  1 | On Loan: —       |
| Quanta Services Inc                                         | Quanta Services Inc                                  | CUSIP: 74762E102<br>LEI: SHVRXXEACT60MMH07S24 | Long             | EC               | CORP              | US        |    312000 | NS      | $47483280.00  | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Sportradar Holding AG                                       | Sportradar Holding AG                                | CUSIP: 000000000<br>LEI: 39120099GMDR0HYDS163 | Long             | EC               | CORP              | CH        |   1092200 | NS      | $13707110.00  | 0.27%             |  |  |  | No            |                  1 | On Loan: —       |
| aTyr Pharma Inc                                             | aTyr Pharma Inc                                      | CUSIP: 002120202<br>LEI: 529900ENQUXMC5EBKO36 | Long             | EC               | CORP              | US        |   2265000 | NS      | $5209500.00   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Advanced Micro Devices Inc                                  | Advanced Micro Devices Inc                           | CUSIP: 007903107<br>LEI: R2I72C950HOYXII45366 | Long             | EC               | CORP              | US        |     15000 | NS      | $1127250.00   | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Barrick Gold Corp                                           | Barrick Gold Corp                                    | CUSIP: 067901108<br>LEI: 0O4KBQCJZX82UKGCBV73 | Long             | EC               | CORP              | CA        |   2003334 | NS      | $39165179.70  | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Chinook Therapeutics Inc                                    | Chinook Therapeutics Inc                             | CUSIP: 16961L106<br>LEI: 549300X0O3003W5QYQ48 | Long             | EC               | CORP              | US        |    450000 | NS      | $11371500.00  | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| FA PRIVATE EQUITY FUND JV, LP                               | FA PRIVATE EQUITY FUND JV, LP                        | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | PF                | US        |         1 | NS      | $370089.00    | 0.01%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Intuitive Surgical Inc                                      | Intuitive Surgical Inc                               | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |     59000 | NS      | $14495710.00  | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Prologis Inc                                                | Prologis Inc                                         | CUSIP: 74340W103<br>LEI: 529900DFH19P073LZ636 | Long             | EC               |  | US        |    400000 | NS      | $51712000.00  | 1.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Sarepta Therapeutics Inc                                    | Sarepta Therapeutics Inc                             | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |    358200 | NS      | $44764254.00  | 0.89%             |  |  |  | No            |                  1 | On Loan: —       |
| S&P Global Inc                                              | S&P Global Inc                                       | CUSIP: 78409V104<br>LEI: Y6X4K52KMJMZE7I7MY94 | Long             | EC               | CORP              | US        |    140000 | NS      | $52491600.00  | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Take-Two Interactive Software Inc                           | Take-Two Interactive Software Inc                    | CUSIP: 874054109<br>LEI: BOMSTHHJK882EWYX3334 | Long             | EC               | CORP              | US        |     65000 | NS      | $7359950.00   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Vail Resorts Inc                                            | Vail Resorts Inc                                     | CUSIP: 91879Q109<br>LEI: 529900PSZHRNU9HKH870 | Long             | EC               | CORP              | US        |     10000 | NS      | $2623400.00   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| REZOLUTE, INC                                               | REZOLUTE, INC                                        | CUSIP: 000000000<br>LEI: N/A                  | N/A              | DE               |  | US        |     56800 | NS      | $145976.00    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| FinecoBank Banca Fineco SpA                                 | FinecoBank Banca Fineco SpA                          | CUSIP: 000000000<br>LEI: 549300L7YCATGO57ZE10 | Long             | EC               | CORP              | IT        |   2102000 | NS      | $37675879.03  | 0.75%             |  |  |  | No            |                  2 | On Loan: No      |
| Argenx SE                                                   | Argenx SE                                            | CUSIP: 000000000<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |    717253 | NS      | $272671622.72 | 5.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Upwork Inc                                                  | Upwork Inc                                           | CUSIP: 91688F104<br>LEI: 5493004QJ6WWBXVE2S70 | Long             | EC               | CORP              | US        |    175000 | NS      | $2268000.00   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| ORCHARD THERAPEUTICS PLC                                    | ORCHARD THERAPEUTICS PLC PIPE DEAL                   | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    530000 | NS      | $294998.00    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| AnaptysBio Inc                                              | AnaptysBio Inc                                       | CUSIP: 032724106<br>LEI: 529900HH4WQT03IG1A12 | Long             | EC               | CORP              | US        |    726923 | NS      | $18093113.47  | 0.36%             |  |  |  | No            |                  1 | On Loan: —       |
| Arcturus Therapeutics Holdings Inc                          | Arcturus Therapeutics Holdings Inc                   | CUSIP: 03969T109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   2449046 | NS      | $51748341.98  | 1.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Duckhorn Portfolio Inc/The                                  | Duckhorn Portfolio Inc/The                           | CUSIP: 26414D106<br>LEI: 2549003BCT5CJSKJ9X51 | Long             | EC               | CORP              | US        |    595644 | NS      | $9637519.92   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Minerva Neurosciences Inc                                   | Minerva Neurosciences Inc                            | CUSIP: 603380205<br>LEI: 54930017PANCHC5LYH79 | Long             | EC               | CORP              | US        |    650000 | NS      | $1553500.00   | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Westinghouse Air Brake Technologies Corp                    | Wabtec Corp/DE                                       | CUSIP: 929740108<br>LEI: 06BTX5UWZD0GQ5N5Y745 | Long             | EC               | CORP              | US        |    385000 | NS      | $39966850.00  | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| CENTURY THERAPEUTICS INC.                                   | CENTURY THERAPEUTICS INC. COMMON                     | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    267745 | NS      | $1223594.65   | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| SCYNEXIS INC WARRANTS                                       | SCYNEXIS INC WARRANTS                                | CUSIP: 000000000<br>LEI: 529900XBHFGMNTU70154 | N/A              | DE               |  | US        |    167251 | NS      | $181801.84    | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Wingstop Inc                                                | Wingstop Inc                                         | CUSIP: 974155103<br>LEI: 549300SSH3F8HPIM3Q47 | Long             | EC               | CORP              | US        |    446684 | NS      | $70786013.48  | 1.40%             |  |  |  | No            |                  1 | On Loan: No      |
| NagaCorp Ltd                                                | NagaCorp Ltd                                         | CUSIP: 000000000<br>LEI: 549300MMNKN0RBJELS20 | Long             | EC               | CORP              | KY        |  22196000 | NS      | $20201160.99  | 0.40%             |  |  |  | No            |                  2 | On Loan: No      |
| Apellis Pharmaceuticals Inc                                 | Apellis Pharmaceuticals Inc                          | CUSIP: 03753U106<br>LEI: 254900HS0ZFRXXSB9D42 | Long             | EC               | CORP              | US        |    156700 | NS      | $8262791.00   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Avidity Biosciences Inc                                     | Avidity Biosciences Inc                              | CUSIP: 05370A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1215600 | NS      | $28809720.00  | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Hamilton Lane Inc                                           | Hamilton Lane Inc                                    | CUSIP: 407497106<br>LEI: 5493006OKN3V1NORM833 | Long             | EC               | CORP              | US        |    699000 | NS      | $54424140.00  | 1.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Philip Morris International Inc                             | Philip Morris International Inc                      | CUSIP: 718172109<br>LEI: HL3H1H2BGXWVG3BSWR90 | Long             | EC               | CORP              | US        |   1000000 | NS      | $104240000.00 | 2.07%             |  |  |  | No            |                  1 | On Loan: No      |
| WELLS FARGO & COMPANY                                       | Wells Fargo & Co                                     | CUSIP: 94988U656<br>LEI: PBLD0EJDB5FWOLXP3B76 | Long             | EP               | CORP              | US        |     25000 | NS      | $617500.00    | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| SCYNEXIS INC WARRANT                                        | SCYNEXIS INC WARRANT EXP 01/01/2099                  | CUSIP: 000000000<br>LEI: N/A                  | N/A              | DE               |  | US        |   1706000 | NS      | $3130510.00   | 0.06%             |  |  |  | No            |                  2 | On Loan: No      |
| PUBLIC STORAGE                                              | Public Storage                                       | CUSIP: 74460W552<br>LEI: 549300LMZF40TKJ6DM64 | Long             | EP               |  | US        |     10000 | NS      | $214100.00    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| CRISPR Therapeutics AG                                      | CRISPR Therapeutics AG                               | CUSIP: 000000000<br>LEI: 506700O6IRRIQLT3W370 | Long             | EC               | CORP              | CH        |    195000 | NS      | $9948900.00   | 0.20%             |  |  |  | No            |                  1 | On Loan: —       |
| Airbnb Inc                                                  | Airbnb Inc                                           | CUSIP: 009066101<br>LEI: 549300HMUDNO0RY56D37 | Long             | EC               | CORP              | US        |    210000 | NS      | $23333100.00  | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Albemarle Corp                                              | Albemarle Corp                                       | CUSIP: 012653101<br>LEI: HDBLS2Q6GV1LSKQPBS54 | Long             | EC               | CORP              | US        |     70000 | NS      | $19701500.00  | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| 89bio Inc                                                   | 89bio Inc                                            | CUSIP: 282559103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9347 | NS      | $109172.96    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Illumina Inc                                                | Illumina Inc                                         | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |     71200 | NS      | $15251040.00  | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| ILLUMINA INC                                                | Illumina Inc                                         | CUSIP: 452327AK5<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | DBT              | CORP              | US        |   3000000 | PA      | $2921514.00   | 0.06%             | 2023-08-15      | None          | 0.00%                 | No            |                  2 | On Loan: No      |
| Rezolute Inc                                                | Rezolute Inc                                         | CUSIP: 76200L309<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   3215300 | NS      | $8263321.00   | 0.16%             |  |  |  | No            |                  1 | On Loan: —       |
| SCYNEXIS Inc                                                | SCYNEXIS Inc                                         | CUSIP: 811292200<br>LEI: 529900XBHFGMNTU70154 | Long             | EC               | CORP              | US        |   1540000 | NS      | $2825900.00   | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| Splunk Inc                                                  | Splunk Inc                                           | CUSIP: 848637104<br>LEI: 549300XGDSGBP6UEI867 | Long             | EC               | CORP              | US        |     70000 | NS      | $6703900.00   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Acrivon Therapeutics Inc                                    | Acrivon Therapeutics Inc                             | CUSIP: 004890109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    800000 | NS      | $12960000.00  | 0.26%             |  |  |  | No            |                  1 | On Loan: —       |
| American Electric Power Co Inc                              | American Electric Power Co Inc                       | CUSIP: 025537101<br>LEI: 1B4S6S7G0TW5EE83BO58 | Long             | EC               | CORP              | US        |    250000 | NS      | $23490000.00  | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| BlackRock Inc                                               | BlackRock Inc                                        | CUSIP: 09247X101<br>LEI: 549300LRIF3NWCU26A80 | Long             | EC               | CORP              | US        |     58900 | NS      | $44717469.00  | 0.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Chipotle Mexican Grill Inc                                  | Chipotle Mexican Grill Inc                           | CUSIP: 169656105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     15850 | NS      | $26095123.00  | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Expand Networks Ltd                                         | EXPAND NETWORKS LTD                                  | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1059322 | NS      | $0.00         | 0.00%             |  |  |  | Yes           |                  3 | On Loan: No      |
| HEICO Corp                                                  | HEICO Corp                                           | CUSIP: 422806109<br>LEI: 529900O1DTDLCJ7L0I14 | Long             | EC               | CORP              | US        |    352000 | NS      | $60174400.00  | 1.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Intellia Therapeutics Inc                                   | Intellia Therapeutics Inc                            | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |    990741 | NS      | $42047048.04  | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Lululemon Athletica Inc                                     | Lululemon Athletica Inc                              | CUSIP: 550021109<br>LEI: 549300D9GZ4BMLDW5T40 | Long             | EC               | CORP              | US        |     57500 | NS      | $17645600.00  | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| MSCI Inc                                                    | MSCI Inc                                             | CUSIP: 55354G100<br>LEI: 549300HTIN2PD78UB763 | Long             | EC               | CORP              | US        |     65000 | NS      | $34551400.00  | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| New Fortress Energy Inc                                     | NEW FORTRESS ENERGY LLC COMMON STOCK                 | CUSIP: 644393100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   2067912 | NS      | $80214306.48  | 1.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Palo Alto Networks Inc                                      | Palo Alto Networks Inc                               | CUSIP: 697435105<br>LEI: 549300QXR2YVZV231H43 | Long             | EC               | CORP              | US        |     10000 | NS      | $1586400.00   | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Physicians Realty Trust                                     | Physicians Realty Trust                              | CUSIP: 71943U104<br>LEI: 549300ITOVH0OY7PZC34 | Long             | EC               |  | US        |   1825000 | NS      | $28944500.00  | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| STARWOOD PROPERTY TRUST                                     | Starwood Property Trust Inc                          | CUSIP: 85571BAH8<br>LEI: BUGSFQZERKRBFWIG5267 | Long             | DBT              | CORP              | US        |   3000000 | PA      | $2995761.00   | 0.06%             | 2023-04-01      | Fixed         | 4.38%                 | No            |                  2 | On Loan: No      |
| Stryker Corp                                                | Stryker Corp                                         | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |     59700 | NS      | $15152457.00  | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Ultragenyx Pharmaceutical Inc                               | Ultragenyx Pharmaceutical Inc                        | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |   1210000 | NS      | $54849300.00  | 1.09%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc                                      | UnitedHealth Group Inc                               | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |     20400 | NS      | $10183476.00  | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| ZoomInfo Technologies Inc                                   | ZoomInfo Technologies Inc                            | CUSIP: 98980F104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    175000 | NS      | $4940250.00   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Catabasis Pharmaceuticals Inc                               | Catabasis Pharmaceuticals Call Exp 22Jun22           | CUSIP: 000000000<br>LEI: 254900VH02JQR2L8XD64 | N/A              | DE               |  | US        |    801900 | NS      | $481.14       | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Genmab A/S                                                  | Genmab A/S                                           | CUSIP: 000000000<br>LEI: 529900MTJPDPE4MHJ122 | Long             | EC               | CORP              | DK        |     64400 | NS      | $25191382.64  | 0.50%             |  |  |  | No            |                  2 | On Loan: No      |
| Moncler SpA                                                 | Moncler SpA                                          | CUSIP: 000000000<br>LEI: 815600EBD7FB00525B20 | Long             | EC               | CORP              | IT        |    326000 | NS      | $20423743.56  | 0.40%             |  |  |  | No            |                  2 | On Loan: No      |
| Merus NV                                                    | Merus NV                                             | CUSIP: 000000000<br>LEI: 549300W8GPUWU8QNU293 | Long             | EC               | CORP              | NL        |   1471143 | NS      | $22949830.80  | 0.45%             |  |  |  | No            |                  1 | On Loan: —       |
| APOLLO INVESTMENT FUND V                                    | APOLLO INVESTMENT FUND V                             | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |         1 | NS      | $85207.00     | 0.00%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Century Therapeutics Inc                                    | Century Therapeutics Inc                             | CUSIP: 15673T100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    250000 | NS      | $1142500.00   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Denali Therapeutics Inc                                     | Denali Therapeutics Inc                              | CUSIP: 24823R105<br>LEI: 549300ZTQ2HO18L3Q830 | Long             | EC               | CORP              | US        |    121500 | NS      | $3677805.00   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Planet Fitness Inc                                          | Planet Fitness Inc                                   | CUSIP: 72703H101<br>LEI: 549300LLE5HUPF6H8G33 | Long             | EC               | CORP              | US        |    375000 | NS      | $31743750.00  | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Q2 Holdings Inc                                             | Q2 Holdings Inc                                      | CUSIP: 74736L109<br>LEI: 549300M9RKR9DZXWS696 | Long             | EC               | CORP              | US        |    250000 | NS      | $8180000.00   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| STAG Industrial Inc                                         | STAG Industrial Inc                                  | CUSIP: 85254J102<br>LEI: 549300QWYX2W6FASVQ07 | Long             | EC               |  | US        |    600000 | NS      | $21360000.00  | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Catabasis Pharmaceuticals Inc                               | Catabasis Pharmaceuticals Wts Catb Wt 6.25           | CUSIP: 000000000<br>LEI: 254900VH02JQR2L8XD64 | N/A              | DE               |  | US        |    421550 | NS      | $84900.17     | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| NAGACORP LTD                                                | NagaCorp Ltd                                         | CUSIP: 000000000<br>LEI: 549300MMNKN0RBJELS20 | Long             | DBT              | CORP              | KY        |   3200000 | PA      | $2976000.00   | 0.06%             | 2024-07-06      | Fixed         | 7.95%                 | No            |                  2 | On Loan: No      |
| Prometheus Biosciences Inc                                  | Prometheus Biosciences Inc                           | CUSIP: 74349U108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    100000 | NS      | $11366000.00  | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| SCYNEXIS INC WARRANT                                        | SCYNEXIS INC WARRANT EXP 05/21/2024                  | CUSIP: 000000000<br>LEI: N/A                  | N/A              | DE               |  | US        |    853000 | NS      | $56980.40     | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Duke Energy Corp                                            | Duke Energy Corp                                     | CUSIP: 26441C204<br>LEI: I1BZKREC126H0VB1BL91 | Long             | EC               | CORP              | US        |    385000 | NS      | $39443250.00  | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| ServiceNow Inc                                              | ServiceNow Inc                                       | CUSIP: 81762P102<br>LEI: 549300HJTQM36M0E1G39 | Long             | EC               | CORP              | US        |     75000 | NS      | $34134750.00  | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| MoonLake Immunotherapeutics                                 | MoonLake Immunotherapeutics                          | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | KY        |    363318 | NS      | $4341650.10   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Gracell Biotechnologies Inc                                 | Gracell Biotechnologies Inc                          | CUSIP: 38406L103<br>LEI: N/A                  | Long             | EC               | CORP              | KY        |    679512 | NS      | $1460950.80   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| United States Treasury                                      | United States Treasury Note/Bond                     | CUSIP: 91282CFV8<br>LEI: 254900HROIFWPRGM1V77 | Long             | DBT              | UST               | US        | 122500000 | PA      | $128796977.75 | 2.55%             | 2032-11-15      | Fixed         | 4.13%                 | No            |                  2 | On Loan: No      |
| Williams Cos Inc/The                                        | Williams Cos Inc/The                                 | CUSIP: 969457100<br>LEI: D71FAKCBLFS2O0RBPG08 | Long             | EC               | CORP              | US        |    175000 | NS      | $5642000.00   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| FEDERATED HERMES INC                                        | Federated Government Obligations Fund                | CUSIP: 60934N104<br>LEI: 254900VAJ9169N7JRF45 | Long             | EC               | RF                | US        |  45476772 | PA      | $45476772.00  | 0.90%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2023-03-23

**Name of Applicant:** Federated Hermes Equity Funds

**Signature:** Stephen Van Meter

**Name of Signer:** Federated Hermes Equity Funds

**Title:** Chief Compliance Officer